Charles Schwab’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$65.7M Buy
481,744
+28,700
+6% +$3.53M 0.01% 1050
2026
Q1
$53.4M Buy
453,044
+22,340
+5% +$3.12M 0.01% 1111
2025
Q4
$70.6M Buy
430,704
+8,616
+2% +$1.35M 0.01% 937
2025
Q3
$56.4M Buy
422,088
+15,825
+4% +$1.92M 0.01% 1084
2025
Q2
$50.5M Buy
406,263
+10,113
+3% +$1.29M 0.01% 1100
2025
Q1
$50.4M Buy
396,150
+18,250
+5% +$2.81M 0.01% 1062
2024
Q4
$54.4M Buy
377,900
+14,521
+4% +$2.08M 0.01% 1072
2024
Q3
$54.1M Buy
363,379
+5,478
+2% +$786K 0.01% 1080
2024
Q2
$45.1M Buy
357,901
+5,690
+2% +$892K 0.01% 1154
2024
Q1
$64.8M Buy
352,211
+9,759
+3% +$1.86M 0.02% 841
2023
Q4
$61.6M Buy
342,452
+15,785
+5% +$2.46M 0.02% 831
2023
Q3
$51.9M Buy
326,667
+8,667
+3% +$1.42M 0.01% 846
2023
Q2
$45M Buy
318,000
+5,742
+2% +$921K 0.01% 919
2023
Q1
$52.6M Buy
312,258
+5,000
+2% +$892K 0.02% 801
2022
Q4
$52M Buy
307,258
+12,365
+4% +$2.24M 0.02% 785
2022
Q3
$55.2M Buy
294,893
+1,030
+0.4% +$217K 0.02% 697
2022
Q2
$47.7M Buy
293,863
+5,678
+2% +$898K 0.02% 775
2022
Q1
$54.2M Buy
288,185
+6,992
+2% +$1.33M 0.02% 819
2021
Q4
$74.5M Buy
281,193
+7,421
+3% +$2M 0.02% 674
2021
Q3
$79.1M Sell
273,772
-109,949
-29% -$28.2M 0.03% 603
2021
Q2
$76.6M Buy
383,721
+9,244
+2% +$1.79M 0.03% 622
2021
Q1
$72.8M Sell
374,477
-11,544
-3% -$2.37M 0.03% 618
2020
Q4
$74M Sell
386,021
-2,322
-0.6% -$422K 0.03% 558
2020
Q3
$57.3M Buy
388,343
+12,830
+3% +$1.83M 0.03% 596
2020
Q2
$46.4M Sell
375,513
-85,392
-19% -$10M 0.02% 651
2020
Q1
$44.5M Buy
460,905
+20,664
+5% +$1.99M 0.03% 576
2019
Q4
$40.7M Buy
440,241
+7,645
+2% +$642K 0.02% 744
2019
Q3
$33.2M Buy
432,596
+134,383
+45% +$11.8M 0.02% 833
2019
Q2
$25.6M Sell
298,213
-5,890
-2% -$401K 0.02% 972
2019
Q1
$18M Buy
304,103
+37,458
+14% +$2.15M 0.01% 1184
2018
Q4
$14.1M Buy
266,645
+52,626
+25% +$3.09M 0.01% 1215
2018
Q3
$11.9M Buy
214,019
+11,818
+6% +$609K 0.01% 1522
2018
Q2
$9.51M Buy
202,201
+11,784
+6% +$485K 0.01% 1636
2018
Q1
$6.89M Sell
190,417
-19,583
-9% -$689K 0.01% 1762
2017
Q4
$7.62M Sell
210,000
-14,388
-6% -$521K 0.01% 1661
2017
Q3
$8.6M Buy
224,388
+8,938
+4% +$375K 0.01% 1530
2017
Q2
$8.93M Sell
215,450
-20,751
-9% -$789K 0.01% 1438
2017
Q1
$8.31M Sell
236,201
-42,611
-15% -$1.35M 0.01% 1437
2016
Q4
$8.59M Buy
278,812
+11,139
+4% +$345K 0.01% 1369
2016
Q3
$8.08M Buy
267,673
+92,083
+52% +$2.78M 0.01% 1317
2016
Q2
$4.8M Buy
175,590
+6,510
+4% +$166K 0.01% 1583
2016
Q1
$4.54M Buy
169,080
+5,426
+3% +$133K 0.01% 1572
2015
Q4
$4.63M Buy
163,654
+15,260
+10% +$440K 0.01% 1571
2015
Q3
$4.13M Buy
148,394
+61,240
+70% +$2.21M 0.01% 1599
2015
Q2
$3.6M Sell
87,154
-160,844
-65% -$5.89M 0.01% 1762
2015
Q1
$7.53M Sell
247,998
-76,353
-24% -$1.98M 0.01% 1208
2014
Q4
$6.42M Sell
324,351
-4,298
-1% -$96.1K 0.01% 1245
2014
Q3
$6.54M Buy
328,649
+117,109
+55% +$2.46M 0.01% 1137
2014
Q2
$4.82M Buy
211,540
+26,160
+14% +$466K 0.01% 1426
2014
Q1
$2.38M Buy
185,380
+99,480
+116% +$1.43M ﹤0.01% 1853
2013
Q4
$1.17M Hold
85,900
﹤0.01% 2192
2013
Q3
$974K Hold
85,900
﹤0.01% 2224
2013
Q2
$722K Buy
+85,900
New +$721K ﹤0.01% 2341

Other funds holding RGEN

Charles Schwab's RGEN Position: Q2 2026 in Review

Charles Schwab increased its Repligen (RGEN) stake by 6.3% in Q2 2026, buying an estimated $3.53M and bringing the position to 481,744 shares worth $65.7M. The position accounts for 0.01% of the portfolio, ranked #1050.

Charles Schwab first reported a position in RGEN in Q2 2013 and has held it in 53 quarters since. The position peaked at $79.1M in Q3 2021. 477 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

  • Charles Schwab held 481,744 shares of Repligen worth $65.7M as of Q2 2026.
  • Charles Schwab bought 28,700 Repligen shares in Q2 2026, an estimated $3.53M.
  • Repligen made up 0.01% of Charles Schwab's portfolio in Q2 2026, its #1050 holding.
  • Charles Schwab first reported a position in Repligen in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Repligen position peaked at $79.1M in Q3 2021.
  • 477 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.